# Prescryptive in the news

Watch our mission unfold. Read how we’re empowering the healthcare industry with our latest news highlights, press releases and more.

## Articles

### As Seen In: Pharmaceutical Commerce

**[Q&A: How direct access and transparency close the patient gap](/content/qa-how-direct-access-and-transparency-close-the-patient-gap/index.html)**  
For decades, pharmaceutical companies have relied on a complex network of intermediaries to help patients access medications.

### As Seen In: Pharmaceutical Executive

**[Modernizing market access and patient support services: Q&A with Cam Olig](/content/modernizing-market-access-and-patient-support-services-qa-with-cam-olig/index.html)**  
New survey highlights growing demand for better patient access.

### As Seen In: Press Release

**[Prescryptive Helps Power LillyDirect®, Supporting Direct-to-Patient Access](/content/prescryptive-helps-power-lillydirect-supporting-direct-to-patient-access/index.html)**  
Redmond, WA – May 6, 2026 – Prescryptive Health today announced it serves as a technology platform helping to…

### As Seen In: Authority Magazine

**[Chief Executive Officer Chris Blackley on the healthcare leadership operating system](/content/chief-executive-officer-chris-blackley-on-the-healthcare-leadership-operating-system/index.html)**  
“A huge challenge for healthcare leaders is that they are being asked to sustain high performance inside systems…

### As Seen In: SHRM

**[GLP-1 pills are here: What does it mean for employers?](/content/glp-1-pills-are-here-what-does-it-mean-for-employers/index.html)**  
Will GLP-1 pills change how employers approach coverage? It’s an important question, but the answer isn't so straightforward.

### As Seen In: EBN

**[As Ozempic costs fall, demand for weight-loss drugs is set to surge](/content/as-ozempic-costs-fall-demand-for-glp-1-weight-loss-drugs-is-set-to-surge/index.html)**  
On the surface, lower GLP-1 prices should make these therapies easier to manage. But as Rae McMahan, SVP…

### As Seen In: Reuters

**[Data shows US advertising spend increasing for pharma manufacturers](/content/data-shows-us-advertising-spend-increasing-for-pharma-manufacturers/index.html)**  
Even with increased availability, access to GLP-1 therapies can be challenging for employers and healthcare consumers due to…

### As Seen In: HIT Consultant

**[Prescryptive and Ilant Health Partner to Deliver Transparent Pricing and Clinical Excellence](/content/prescryptive-and-ilant-health-partner-to-deliver-transparent-pricing-and-clinical-excellence/index.html)**  
Access is the new standard – and with partners like Ilant Health, Prescryptive is delivering it. Our collaboration…

### As Seen In: Press Release

**[Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale](/content/prescryptive-and-ilant-health-expand-employer-direct-access-to-obesity-care-and-transparent-glp-1-access-at-scale/index.html)**  
Redmond, WA – Friday, Jan. 9, 2026 — Prescryptive and Ilant Health today announced a collaboration to help…

### As Seen In: EBN

**[A broker’s guide to breaking the rebate cycle](/content/a-brokers-guide-to-breaking-the-rebate-cycle/index.html)**  
Prescription drug costs are among the fastest-growing and most unpredictable healthcare expenses employers face. According to recent data,…

### As Seen In: Drug Topics

**[Navigating GLP-1 access & complexity: 4 key insights](/content/navigating-glp-1-access-complexity-4-key-insights/index.html)**  
Glucagon-like peptide-1 (GLP-1) therapies are reshaping care for diabetes, obesity, and cardiometabolic health. Yet with their rapid rise…